本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Abivax S.A.

81.99
+0.96001.18%
盤後81.990.00000.00%18:55 EDT
成交量:59.25萬
成交額:4,816.46萬
市值:61.62億
市盈率:-25.79
高:82.51
開:80.01
低:80.01
收:81.03
52周最高:82.51
52周最低:4.77
股本:7,515.13萬
流通股本:3,877.21萬
量比:0.57
換手率:1.53%
股息:- -
股息率:- -
每股收益(TTM):-3.1785
每股收益(LYR):-2.8941
淨資產收益率:-196.12%
總資產收益率:-48.60%
市淨率:-804.18
市盈率(LYR):-28.33

資料載入中...

2025/07/24

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/07/23

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/03/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/25

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/31

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/20

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/18

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/16

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/16

SEC問詢函

Form CORRESP - Correspondence
2023/09/29

SEC問詢函

Form CORRESP - Correspondence